Skip to main content

McKesson Corp

corporate_fare Company Profile

McKesson Corp

MCK·NYSE·Trade & Services·CIK 0000927653

McKesson Corporation is a diversified healthcare services leader that works to improve health outcomes for patients globally. The company partners with biopharma companies, care providers, pharmacies, manufacturers, and governments to provide insights, products, and services aimed at making quality care more accessible and affordable. McKesson's business roots trace back to 1833, and it was incorporated in Delaware on July 7, 1994. The company's fiscal year runs from April 1 to March 31. Starting in the second quarter of fiscal 2026, McKesson implemented a new segment reporting structure, resulting in four reportable segments: North American Pharmaceutical, Oncology & Multispecialty, Prescription Technology Solutions, and Medical-Surgical Solutions.

McKesson Corp (NYSE:MCK) is a publicly traded company in the Trade & Services sector. Wiseek has independently scored 26 items for MCK at importance 7 or higher on its 1–10 market-impact scale.

Recent high-impact activity:

  • Apollo Funds Invest $1.25B for 13% Minority Stake in McKesson's Medical-Surgical Unit
  • McKesson Secures $2.0 Billion in New Credit Facilities for Refinancing and General Corporate Purposes
  • McKesson Reaffirms Fiscal 2026 Outlook and Sets Q4 Earnings Date Amid CFO Transition
  • McKesson Announces Planned CFO Transition, Appoints Experienced Finance Leader
  • McKesson Reports Strong Q3 Earnings, Strategic Acquisitions, and Shareholder Returns

Financial Snapshot

Fiscal year ended March 31, 2026
Revenue
$403.43B
Net Income
$4.76B
Diluted EPS
$38.38
Op. Cash Flow
$6.16B
Free Cash Flow
$5.72B
Gross Profit
$14.55B
Operating Income
$6.21B
Cash & Equivalents
$3.98B
Total Debt
$6.53B
Debt / Equity
-3.00×
Net Margin
1.2%
Shares Outstanding
123.6M sh
Source: 10-K · filed 2026-05-07 · accession 0000927653-26-000069
$1070 +0.03% today
52-week range · as of 2026-11-04 $723.68 – $1073.95
Market cap
$123.51B
Volume
869.5K (1.2× avg)
3-mo avg 717.9K
Live data · 2026-11-22 12:46 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed MCK - Filings & News (Page 2)

MCK
Apr 20, 2026, 8:03 AM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $860.01
Real-time Price: $1,070.00 info
Change: +$209.99 (+24%) info
Market Cap: $123.506B info
MCK
Apr 06, 2026, 8:03 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $888.00
Real-time Price: $1,070.00 info
Change: +$182.00 (+20%) info
Market Cap: $123.506B info
MCK
Mar 06, 2026, 8:04 AM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $947.90
Real-time Price: $1,070.00 info
Change: +$122.10 (+13%) info
Market Cap: $123.506B info
MCK
Mar 05, 2026, 8:16 AM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $965.00
Real-time Price: $1,070.00 info
Change: +$105.00 (+11%) info
Market Cap: $123.506B info
MCK
Feb 04, 2026, 5:30 PM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $836.50
Real-time Price: $1,070.00 info
Change: +$233.50 (+28%) info
Market Cap: $123.506B info
MCK
Feb 04, 2026, 4:05 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $822.00
Real-time Price: $1,070.00 info
Change: +$248.00 (+30%) info
Market Cap: $123.506B info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets